Viamet Pharmaceuticals, Inc., a world leader in the development of best-in-class therapies targeting metalloenzymes, announced today that Robert Schotzinger, M.D., Ph.D., President and CEO of Viamet, will present an overview of the Company at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 14, beginning at 8:00 a.m. Pacific Time. The presentation will be held in the Elizabethan C Ballroom at the Westin St. Francis Hotel.
Help employers find you! Check out all the jobs and post your resume.
